{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:00:57Z","timestamp":1777910457899,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,12,18]],"date-time":"2002-12-18T00:00:00Z","timestamp":1040169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,18]],"date-time":"2002-12-18T00:00:00Z","timestamp":1040169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2003,1,1]]},"DOI":"10.1038\/sj.cgt.7700524","type":"journal-article","created":{"date-parts":[[2003,2,20]],"date-time":"2003-02-20T15:46:17Z","timestamp":1045755977000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Choon-Taek","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja Young","family":"Seol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Gyu","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Whan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Koo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Soo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Coffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail M","family":"Dikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,18]]},"reference":[{"key":"BF7700524_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/0092-8674(94)90023-X","volume":"79","author":"R Baserga","year":"1994","unstructured":"Baserga R . Oncogenes and the strategy of growth factor. Cell. 1994; 79: 927\u2013930.","journal-title":"Cell"},{"key":"BF7700524_CR2","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1002\/j.1460-2075.1986.tb04528.x","volume":"5","author":"A Ullrich","year":"1986","unstructured":"Ullrich A, Gray A & Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986; 5: 2503\u20132512.","journal-title":"EMBO J"},{"key":"BF7700524_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/excr.1999.4667","volume":"253","author":"R Baserga","year":"1999","unstructured":"Baserga R . The IGF-I receptor in cancer research. Exp Cell Res. 1999; 253: 1\u20136.","journal-title":"Exp Cell Res"},{"key":"BF7700524_CR4","first-page":"F105","volume":"1332","author":"R Baserga","year":"1997","unstructured":"Baserga R . The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta. 1997; 1332: F105\u2013F126.","journal-title":"Biochim Biophys Acta"},{"key":"BF7700524_CR5","first-page":"2218","volume":"54","author":"M Resnikoff","year":"1994","unstructured":"Resnikoff M, Sell C & Rubini M, et al. Rat glioblastoma cells expressing an antisense RNA to insulin-like growth factor I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 1994; 54: 2218\u20132222.","journal-title":"Cancer Res"},{"key":"BF7700524_CR6","first-page":"4848","volume":"54","author":"M Resnicoff","year":"1994","unstructured":"Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S & Baserga R . Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 1994; 54: 4848\u20134850.","journal-title":"Cancer Res"},{"key":"BF7700524_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1073\/pnas.91.6.2181","volume":"91","author":"D Prager","year":"1994","unstructured":"Prager D, Li HL, Asa S & Melmed S . Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA. 1994; 91: 2181\u20132185.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700524_CR8","first-page":"663","volume":"55","author":"M Miura","year":"1995","unstructured":"Miura M, Li S & Baserga R . Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res. 1995; 55: 663\u2013667.","journal-title":"Cancer Res"},{"key":"BF7700524_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/bbrc.1995.2311","volume":"214","author":"JL Burgaud","year":"1995","unstructured":"Burgaud JL, Resnikoff M & Baserga R . Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun. 1995; 214: 475\u2013481.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF7700524_CR10","first-page":"2647","volume":"4","author":"K Reiss","year":"1998","unstructured":"Reiss K, D'Ambrosio C, Tu X, Tu C & Baserga R . Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin Cancer Res. 1998; 4: 2647\u20132655.","journal-title":"Clin Cancer Res"},{"key":"BF7700524_CR11","first-page":"3353","volume":"58","author":"SE Dunn","year":"1998","unstructured":"Dunn SE, Ehrlich M & Sharp NJ, et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998; 58: 3353\u20133361.","journal-title":"Cancer Res"},{"key":"BF7700524_CR12","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1073\/pnas.94.11.5854","volume":"94","author":"F Rininsland","year":"1997","unstructured":"Rininsland F, Johnson TR & Chernicky CL, et al. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc Natl Acad Sci USA. 1997; 94: 5854\u20135859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700524_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1385\/0-89603-178-0:109","volume-title":"Gene Transfer and Expression Protocols","author":"FL Graham","year":"1991","unstructured":"Graham FL & Prevec L . Manipulation of adenovirus vectors. In: Murray E, edGene Transfer and Expression Protocols, Clifton, NJ: Humana Press; 1991; 109\u2013128."},{"key":"BF7700524_CR14","first-page":"15","volume":"1","author":"DC Tang","year":"1994","unstructured":"Tang DC, Johnston SA & Carbone DP . Tumor-restricted gene expression by adenovirus-mediated gene transfer. Cancer Gene Ther. 1994; 1: 15\u201320.","journal-title":"Cancer Gene Ther"},{"key":"BF7700524_CR15","first-page":"3038","volume":"56","author":"C-T Lee","year":"1996","unstructured":"Lee C-T, Wu S & Gabrilovich D, et al. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res. 1996; 56: 3038\u20133041.","journal-title":"Cancer Res"},{"key":"BF7700524_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","volume-title":"Protein Expression in Animal Cells","author":"TC Becker","year":"1994","unstructured":"Becker TC, Noel RJ & Coats WS, et al. Use of recombination of adenovirus for metabolic engineering of mammalian cells. In: Roth MG, edProtein Expression in Animal Cells, New York: Academic Press; 1994; 161\u2013188."},{"key":"BF7700524_CR17","first-page":"3831","volume":"56","author":"SO Kim","year":"1996","unstructured":"Kim SO, Park JG & Lee YI . Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene products. Cancer Res. 1996; 56: 3831\u20133836.","journal-title":"Cancer Res"},{"key":"BF7700524_CR18","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1128\/MCB.18.11.6711","volume":"18","author":"G Kulik","year":"1998","unstructured":"Kulik G, Klippel A & Weber MJ . Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol. 1998; 18: 1595\u20131606.","journal-title":"Mol Cell Biol"},{"key":"BF7700524_CR19","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1128\/MCB.18.11.6711","volume":"18","author":"G Kulik","year":"1998","unstructured":"Kulik G & Weber MJ . Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor-I. Mol Cell Biol. 1998; 18: 6711\u20136718.","journal-title":"Mol Cell Biol"},{"key":"BF7700524_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/BF03345480","volume":"22","author":"A Grimberg","year":"1999","unstructured":"Grimberg A & Cohen P . Growth hormone and prostate cancer: guilty by association?. J Endocrinol Invest. 1999; 22: 64\u201373.","journal-title":"J Endocrinol Invest"},{"key":"BF7700524_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/91.7.620","volume":"91","author":"J Ma","year":"1999","unstructured":"Ma J, Pollack MN & Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999; 91: 620\u2013625.","journal-title":"J Natl Cancer Inst"},{"key":"BF7700524_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/jnci\/91.2.151","volume":"91","author":"H Yu","year":"1999","unstructured":"Yu H, Spitz MR, Mistry J, Gu J, Hong WK & Wu X . Plasma levels of insulin-like growth factor-I and lung cancer risk: a case control analysis. J Natl Cancer Inst. 1999; 91: 151\u2013156.","journal-title":"J Natl Cancer Inst"},{"key":"BF7700524_CR23","first-page":"4127","volume":"58","author":"K Scotland","year":"1999","unstructured":"Scotland K, Benini S & Nani P, et al. Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic nude mice. Cancer Res. 1999; 58: 4127\u20134131.","journal-title":"Cancer Res"},{"key":"BF7700524_CR24","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1073\/pnas.89.11.4874","volume":"89","author":"J Trojan","year":"1992","unstructured":"Trojan J, Blossey BK & Johnson TR, et al. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA. 1992; 89: 4874\u20134878.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF7700524_CR25","first-page":"2477","volume":"58","author":"A Hongo","year":"1998","unstructured":"Hongo A, Yumet G, Resnicoff M, Romano G, O'Connor R & Baserga R . Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristoylated COOH terminus of insulin-like growth factor I receptor. Cancer Res. 1998; 58: 2477\u20132484.","journal-title":"Cancer Res"},{"key":"BF7700524_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta SR, Dudek H & Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997; 91: 231\u2013241.","journal-title":"Cell"},{"key":"BF7700524_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.278.5338.687","volume":"278","author":"L del Peso","year":"1997","unstructured":"del Peso L, Gonzalez-Garcia M, Page C, Herrera R & Nunez G . Interleukin-3\u2013induced phosphorylation of BAD through the protein kinase Akt. Science. 1997; 278: 687\u2013689.","journal-title":"Science"},{"key":"BF7700524_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1074\/jbc.272.1.154","volume":"272","author":"M Parrizas","year":"1997","unstructured":"Parrizas M, Saltiel AR & LeRoith D . Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J Biol Chem. 1997; 272: 154\u2013161.","journal-title":"J Biol Chem"},{"key":"BF7700524_CR29","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.1128\/MCB.19.10.7203","volume":"19","author":"F Peruzzi","year":"1999","unstructured":"Peruzzi F, Prisco M & Dews M, et al. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol. 1999; 19: 7203\u20137215.","journal-title":"Mol Cell Biol"},{"key":"BF7700524_CR30","first-page":"4013","volume":"56","author":"C D'Ambrosio","year":"1996","unstructured":"D'Ambrosio C, Ferber A, Resnicoff M & Baserga R . A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 1996; 56: 4013\u20134020.","journal-title":"Cancer Res"},{"key":"BF7700524_CR31","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/sj.onc.1202984","volume":"18","author":"Y Jiang","year":"1999","unstructured":"Jiang Y, Rom WN, Yie T-A, Chi CX & Tchou-Wong K-M . Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene. 1999; 18: 6071\u20136077.","journal-title":"Oncogene"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7700524","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7700524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:03:14Z","timestamp":1647957794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7700524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1,1]]}},"alternative-id":["BF7700524"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7700524","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,18]]},"assertion":[{"value":"22 August 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2002","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}